Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 7/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.56 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.56 |
| ▸ | CES2 | O00748 | 3/20 | 0.54 |
| ▸ | CES1 | P23141 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Decanoic Acid SCHEMBL194214 | 1.00 | FABP3 (0.60) | FABP3NFKB1CA1GPR84DNM1 | |
| Palmitic Acid SCHEMBL28907711 | 1.00 | FABP3 (0.60) | FABP3NFKB1CA1GPR84DNM1 | |
| Decanoic Acid SCHEMBL6544079 | 1.00 | FABP3 (0.60) | FABP3NFKB1CA1GPR84DNM1 | |
| Hexanoate SCHEMBL11176554 | 1.00 | FABP3 (0.60) | FABP3NFKB1CA1GPR84DNM1 | |
| Myristic Acid SCHEMBL20489379 | 1.00 | FABP3 (0.60) | FABP3NFKB1CA1GPR84DNM1 | |
| Hexanoate SCHEMBL17839050 | 1.00 | FABP3 (0.60) | FABP3NFKB1CA1GPR84DNM1 | |
| Octanoic Acid SCHEMBL11573973 | 1.00 | FABP3 (0.60) | FABP3NFKB1CA1GPR84DNM1 | |
| Octanoic Acid SCHEMBL17453697 | 1.00 | FABP3 (0.60) | FABP3NFKB1CA1GPR84DNM1 | |
| Octanoic Acid SCHEMBL16007959 | 0.98 | DNM1 (0.60) | FABP3NFKB1CA1GPR84DNM1 | |
| Hexanoate SCHEMBL29936528 | 0.98 | FABP3 (0.58) | FABP3NFKB1CA1GPR84DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108949889-B | Method for preparing androstenedione through phytosterol biotransformation in quaternary phosphonium salt ionic liquid/water two-phase system | 浙江大学 | 2021-02-05 | — | — | CN | disclosed |
| EP-3233872-B1 | QUATERNARY CARBOXYLATE COMPOSITIONS FOR EXTRACTING C1 TO C4 CARBOXYLIC ACIDS FROM AQUEOUS STREAMS | EASTMAN CHEM CO (US) | 2019-10-30 | — | — | EP | disclosed |
| US-9573078-B2 | Quaternary carboxylate compositions for extracting C1 to C4 carboxylic acids from aqueous streams | EASTMAN CHEMICAL COMPANY (US) | 2017-02-21 | — | — | US | disclosed |
| US-20160175737-A1 | Quaternary Carboxylate Compositions for Extracting C1 to C4 Carboxylic Acids from Aqueous Streams | EASTMAN CHEMICAL COMPANY (US) | 2016-06-23 | — | — | US | disclosed |
| US-7759401-B2 | Nanoporous and microporous solvogels and nanolatexes by microemulsion polymerization | EASTERN MICHIGAN UNIVERSITY (US) | 2010-07-20 | — | — | US | disclosed |
| US-20090176915-A1 | NANOPOROUS AND MICROPOROUS SOLVOGELS AND NONOLATEXES BY MICROEMULSION POLYMERIZATION | EASTERN MICHIGAN UNIVERSITY | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160175737-A1 | Quaternary Carboxylate Compositions for Extracting C1 to C4 Carboxylic Acids from Aqueous Streams | SLC16A3, CA4, SLC16A1 | FABP3 534/4885NFKB1 1523/4885CA1 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.